Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 43,237 | 43,745 | 36,821 | 35,855 | 31,418 |
| Operating Income | -43,237 | -43,745 | -36,821 | -35,855 | -31,418 |
| Other Income | 4,650 | 4,127 | 1,759 | 928 | 784 |
| Pre-tax Income | -38,587 | -39,618 | -35,062 | -34,927 | -30,634 |
| Net Income Continuous | -38,587 | -39,618 | -35,062 | -34,927 | -30,634 |
| Net Income | $-38,587 | $-39,618 | $-35,062 | $-34,927 | $-30,634 |
| EPS Basic Total Ops | -0.55 | 0.16 | -0.50 | -0.71 | -0.68 |
| EPS Basic Continuous Ops | -0.55 | -0.50 | -0.50 | -0.71 | -0.68 |
| EPS Diluted Total Ops | -0.55 | 0.16 | -0.50 | -0.71 | -0.68 |
| EPS Diluted Continuous Ops | -0.55 | -0.50 | -0.50 | -0.71 | -0.68 |
| EBITDA(a) | $-43,751 | $-44,507 | $-37,021 | $-35,758 | $-31,349 |